pNGVL4a-Sig/E7(detox)/HSP700 (PapiVax Biotech)

N/A

Report date: 2026/05/13 15:37:32

Base Information

Drug NamepNGVL4a-Sig/E7(detox)/HSP700 (PapiVax Biotech)

Drug Alias NamepNGVL4a-Sig/E7(detox)/HSP70 plasmid DNATA-HPV vaccinia viruspNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPVPVX-2PVX-1

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPrecancerous ConditionsNeoplasm MetastasisUterine Cervical Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesParexel International Corp Papivax Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesParexel International Corp Papivax Biotech Inc National Cancer Institute

Inactive CompaniesN/A

Active IndicationsPrecancerous ConditionsNeoplasm MetastasisUterine Cervical Neoplasms +[4]

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A